This site is intended for healthcare professionals
Optimising anti-TNF treatment using biosimilars Learning Zone

Welcome

Read time: 65 mins
Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.

This Learning Zone has been developed to provide practical advice and considerations on the use of biosimilars covering such topics as timely initiation, dose optimisation, the role of therapeutic drug monitoring, and cycling vs switching for anti-TNFs. 

The importance of shared decision-making to improve adherence and persistence are also discussed, as well as how biosimilars are shaping anti-TNF exit strategies.

Register for free exclusive healthcare eLearning resources


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest